Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the ...

The new tariffs, effective 1 October, are also aimed at kitchen cabinets, bathroom vanities & heavy trucks. Any levies on ...

Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future ...

UK shoppers are the most budget-conscious in the world when it comes to wellness, says Alex Heffernan, insight manager for ...

Weight management drugs like the GLP-1 can significantly improve health outcomes, but their exorbitant prices often limit ...

"The findings are very exciting,” said Dr. Prachi Singh at Pennington Biomedical. “This supports the growing understanding ...

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

New research unveils a groundbreaking quintuple agonist that targets multiple pathways for effective treatment of obesity and ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...

Having spun off its sugar division, Tate & Lyle is now focused on sweetening, mouthfeel and fortification in a $5bn bet on ...